NHS Logo
  • Home
  • Impact
  • About Us
    • Contact Us
    • NIHR Imperial BRC Team
    • Equality, Diversity and Inclusion (EDI) Strategy
    • NIHR Infrastructures
    • Acknowledgement
    • Research Guidance & Useful Links
    • NIHR Imperial BRC Branding Guidance
  • Research
    • Biomedical Engineering
    • Brain Sciences
    • Cardiovascular
    • Digestive Diseases
    • Digital Health
    • Immunology
    • Infection & Antimicrobial Resistance
    • Metabolic & Endocrinology
    • Molecular Phenotyping
    • Multiple Long-term Conditions (MLTC)
    • Pregnancy & Prematurity
    • Respiratory
    • Social, Genetic & Environmental Determinants of Health (SGE)
    • Surgery & Cancer
  • Facilities/Services
    • Clinical Imaging Facility
    • Clinical Phenotyping Centre
    • Flow Cytometry
    • Genomics Facility
    • Imperial College Healthcare Tissue Bank
    • iCARE
    • Imperial Clinical Trials Unit
    • Imperial Health Knowledge Bank (IHKB)
    • Organoid Facility
    • Patient Experience Research Centre (PERC)
    • The Leonard and Dora Colebrook Laboratory
  • Patient/Public
    • Research We Are Supporting
    • How You Can Get Involved
    • Information for Researchers
    • Public Involvement, Engagement and Participation in Research Summary Strategy
  • Industry/Partners
    • Collaborations
    • Contract
    • Commercialisation
  • Training
    • Non-Medical Opportunities
    • Chain Florey Clinician Scientist Programme
    • Clinical Academic Training Office
    • Other Training Schemes
  • News & Events
    • Upcoming Events
    • Newsletter

Prevention Stories

InnovationPartnershipPrevention Cancer leading cause of death in those with diabetes

InnovationPartnershipPrevention Cancer leading cause of death in those with diabetes

Published on 5th February 2021
DiagnosticInformatics ApproachesPrevention Blood plasma treatment has limited effect for sickest COVID-19 patients

DiagnosticInformatics ApproachesPrevention Blood plasma treatment has limited effect for sickest COVID-19 patients

Published on 13th January 2021
DiagnosticInnovationPrevention Potential new biomarkers for detecting risk of small-for-gestational-age births

DiagnosticInnovationPrevention Potential new biomarkers for detecting risk of small-for-gestational-age births

Published on 12th January 2021
DiagnosticPrevention Newly described condition causes loss of vertigo and imbalance in TBI patients

DiagnosticPrevention Newly described condition causes loss of vertigo and imbalance in TBI patients

Published on 8th January 2021
PreventionTherapeutic Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients

PreventionTherapeutic Arthritis drugs may reduce mortality and time in ICU for sickest COVID patients

Published on 8th January 2021
Information for Patients and the Public
  • Research We Are Supporting
  • How You Can Get Involved
  • Public Involvement, Engagement and Participation in Research Summary Strategy
Latest News
  • Diagnostic Inflammatory Marker Predicts 20-Year Cardiovascular Risk in Patients with Hypertension
  • Guideline Inequalities in Intensive Care Outcomes for Children Highlighted in New Study
  • Prevention Study uncovers the positive aspects of weight loss in human fat tissue
NIHR Imperial Biomedical Research Centre

The National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre (BRC) is part of the NIHR and hosted by Imperial College Healthcare NHS Trust in partnership with Imperial College London


Accessibility
Privacy
Terms & Conditions

The information contained in this website is for general use only. We endeavour to keep the information on the site up to date and correct, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose.

© 2025 - NIHR Imperial Biomedical Research Centre